[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366660-105":59,"doc-detail-366660-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","reproducible-autosomal-gene-expression-changes-with-loss-of-typical-x-and-y-complement-across-tumor-types-reproducible-sex-chromosome-effects","Reproducible autosomal gene expression changes with loss of typical X and Y complement across tumor types - Reproducible sex chromosome effects","","Although sex differences in cancer incidence, severity, and treatment are well documented, sex chromosomes are often omitted from genomic analyses due to technical challenges in measuring copy number, sequence variation, and expression. This study evaluates sex chromosome complement across three widely used human genomics datasets spanning normal tissues, primary tumors, and cancer cell lines, and links complement states to genome-wide gene expression patterns. Tumors show recurrent loss of Y (LOY), loss of X (LOX), and inactive X reactivation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/reproducible-autosomal-gene-expression-changes-with-loss-of-typical-x-and-y-complement-across-tumor-types-reproducible-sex-chromosome-effects/366660/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/reproducible-autosomal-gene-expression-changes-with-loss-of-typical-x-and-y-complement-across-tumor-types-reproducible-sex-chromosome-effects/366660.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are sex chromosomes commonly excluded from genomic analyses in cancer research?","Question",{"text":112,"@type":113},"Sex chromosomes are typically left out because assessing their copy number, sequence variation, and expression poses unique technical challenges.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What types of sex chromosome complement changes were assessed in tumors and cell lines?",{"text":117,"@type":113},"The study focuses on three main complement-related patterns: loss of chromosome Y (LOY), loss of chromosome X (LOX), and reactivation of the inactive X chromosome (XaXa).",{"name":119,"@type":110,"acceptedAnswer":120},"How do LOX and LOY relate to patient outcomes and gene expression differences between sexes?",{"text":121,"@type":113},"Patients with tumors showing LOX or LOY had poorer survival outcomes. LOX and LOY also largely eliminate differential gene expression between tumors from different patient sexes by affecting both sex-chromosomal and autosomal expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366660,1790729994,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","bioRxiv preprint doi: [https://doi.org/10.1101/2025.09.24.678401](https://doi.org/10.1101/2025.09.24.678401); this version posted September 25, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC  \n105 and is also made available for use under a CC0 license.  \n1 Reproducible autosomal gene expression changes with loss of typical X and Y complement  \n2 across tumor types (short: Reproducible sex chromosome effects) 3  \n4 Authors  \n5 Seema B. Plaisier 1,2,3, Robert Phavong 1, Mason Farmwald 1, Mariah Lee 1, Teagen Allen 1, Malli  \n6 Swamy 1, Ilsa Rodriguez 1 , MacKenzie Wells 1, Nadia Phaneuf1, Susan Christine Massey 1, Jared  \n7 Del Rosario 1, Juvelyn Hart 1, Alexander Mangelsdorf1, Martin Van Der Jagt 1, Alex R. DeCasien4,  \n8 Kenneth H. Buetow 1,2, Melissa A. Wilson 1,2,3 * 9  \n10 Affiliations  \n11 1. School of Life Sciences, Arizona State University, Tempe, Arizona, 85281  \n12 2. Center for Evolution and Medicine, Arizona State University, Tempe, Arizona, 85281  \n13 3. Center for Genomics and Data Science Research, National Human Genome Research  \n14 Institute, National Institutes of Health, Bethesda, MD, 20852 USA  \n15 4. Computational and Evolutionary Neurogenomics Unit, National Institute on Aging,  \n16 National Institutes of Health, Bethesda, MD, 20852 USA 17  \n18 * Corresponding Author: Melissa A. Wilson, [melissa.wilson3@nih.gov](melissa.wilson3@nih.gov)[ ](melissa.wilson3@nih.gov)19  \n20 Abstract 21  \n22 Although there are known sex differences in cancer incidence, severity, and treatment, the sex  \n23 chromosomes are typically excluded from genomic analyses because of the unique technical  \n24 challenges associated with assessing their copy number, sequence variation, and expression. Here  \n25 we assess sex chromosome complement in three widely-used human genomics datasets from  \n26 normal (non-cancerous) tissues, primary tumors, and cancer cell lines and study the effects on  \n27 genome-wide gene expression. Expected sex chromosome complements based on reported patient  \n28 sex were observed in non-cancerous tissues, but about half of tumors and cancer cell lines showed  \n29 loss of typical sex chromosome gene expression across tissue types with three categories: loss of  \n30 chromosome Y (LOY), loss of chromosome X (LOX) and reactivation of the inactive X  \n31 chromosome (XaXa) . Genes consistently differentially expressed in tumors with loss of  \n32 chromosome X, loss of chromosome Y, or loss of X chromosome inactivation are associated with  \n33 the hallmarks of cancer and include both sex-linked and autosomal genes from nearly all  \n34 chromosomes, druggable genes, and genes with molecular functions relevant to cancer signaling,  \n35 such as kinase activity. Strikingly, tumors that are X0, including tumors from female patients that  \n36 have lost an X chromosome and tumors from male patients that have lost a Y chromosome, cluster  \n37 together by gene expression profile. Patients with tumors that have LOX or LOY had poorer  \n38 survival outcomes compared to those with tumors that had maintained their sex chromosome  \n39 complement. Further, LOX and LOY eliminates nearly all of the differential gene expression  \n40 between tumors from different patient sexes, affecting sex chromosomal and autosomal gene  \n41 expression. Going forward, considering patient sex as well as the entire genome, including  \n42 assessment of the sex chromosome complement, will provide additional insights into personalized  \n43 tumor etiology, progression, treatment, and patient outcome.  \n44  \n45 Teaser 46  \n47 Loss of typical sex chromosome complement is present in primary tumors and cancer cell lines  \n48 across tissue types. We identify consistent autosomal gene expression changes across multiple  \n49 cancers when the sex chromosome complement is altered, and show that loss of sex chromosomes  \nbioRxiv","cbCaiog9xELrvu6S","https://ap.wps.com/l/cbCaiog9xELrvu6S","pdf",2933099,33,"English","# Abstract\n## Loss of typical X and Y complement\n## Differential gene expression across tumors\n## Survival associations and clinical implications","[{\"question\":\"Why are sex chromosomes commonly excluded from genomic analyses in cancer research?\",\"answer\":\"Sex chromosomes are typically left out because assessing their copy number, sequence variation, and expression poses unique technical challenges.\"},{\"question\":\"What types of sex chromosome complement changes were assessed in tumors and cell lines?\",\"answer\":\"The study focuses on three main complement-related patterns: loss of chromosome Y (LOY), loss of chromosome X (LOX), and reactivation of the inactive X chromosome (XaXa).\"},{\"question\":\"How do LOX and LOY relate to patient outcomes and gene expression differences between sexes?\",\"answer\":\"Patients with tumors showing LOX or LOY had poorer survival outcomes. LOX and LOY also largely eliminate differential gene expression between tumors from different patient sexes by affecting both sex-chromosomal and autosomal expression.\"}]","Reproducible autosomal gene expression changes with loss of typical X and Y complement across tumor types - Reproducible sex chromosome effects | PDF",1790166605,83,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c68cb963eb797205d9328fd4e7550de3.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9970820faa3f49095c4ad1c5da2f7cfa.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84b4d419ca5f18b324c40080e6a9568c.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42f354358132164ce052ba1a33bf596a.webp",980,1268]